Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PAOX | Q6QHF9 | 5/20 | 1.00 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.76 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.76 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.76 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.59 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.51 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.51 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.49 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.49 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.49 |
| ▸ | MAOA | P21397 | 1/20 | 0.48 |
| ▸ | MAOB | P27338 | 1/20 | 0.48 |
| ▸ | KDM4A | O75164 | 1/20 | 0.46 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.46 |
| ▸ | DOHH | Q9BU89 | 1/20 | 0.46 |
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31532946 | 1.00 | PAOX (1.00) | PAOXHIF1AKDM4EMAPK1ADRA1A | |
| SCHEMBL1409002 | 1.00 | PAOX (1.00) | PAOXHIF1AKDM4EMAPK1ADRA1A | |
| SCHEMBL19816770 | 1.00 | PAOX (1.00) | PAOXHIF1AKDM4EMAPK1ADRA1A | |
| SCHEMBL1408891 | 1.00 | PAOX (1.00) | PAOXHIF1AKDM4EMAPK1ADRA1A | |
| SCHEMBL346746 | 1.00 | PAOX (1.00) | PAOXHIF1AKDM4EMAPK1ADRA1A | |
| SCHEMBL1409041 | 1.00 | PAOX (1.00) | PAOXHIF1AKDM4EMAPK1ADRA1A | |
| SCHEMBL7552315 | 1.00 | PAOX (1.00) | PAOXHIF1AKDM4EMAPK1ADRA1A | |
| SCHEMBL12006469 | 1.00 | PAOX (1.00) | PAOXHIF1AKDM4EMAPK1ADRA1A | |
| SCHEMBL21842271 | 1.00 | PAOX (1.00) | PAOXHIF1AKDM4EMAPK1ADRA1A | |
| SCHEMBL1409025 | 1.00 | PAOX (1.00) | PAOXHIF1AKDM4EMAPK1ADRA1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 238 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3611254-B1 | MICROORGANISMS AND METHODS FOR THE BIOSYNTHESIS OF HEXAMETHYLENEDIAMINE | GENOMATICA INC (US) | 2023-07-05 | — | — | EP | claimed |
| WO-2012177721-A1 | MICROORGANISMS FOR PRODUCING 6-AMINOCAPROIC ACID | GENOMATICA, INC. (US) | 2012-12-27 | — | — | WO | claimed |
| EP-2427544-A1 | MICROORGANISMS AND METHODS FOR THE BIOSYNTHESIS OF ADIPATE, HEXAMETHYLENEDIAMINE AND 6-AMINOCAPROIC ACID | Genomatica, Inc. (US) | 2012-03-14 | — | — | EP | claimed |
| WO-2010129936-A1 | MICROORGANISMS AND METHODS FOR THE BIOSYNTHESIS OF ADIPATE, HEXAMETHYLENEDIAMINE AND 6-AMINOCAPROIC ACID | GENOMATICA, INC. (US) | 2010-11-11 | — | — | WO | claimed |
| US-6462028-B2 | P2Y2 AND/OR P2Y4 PURINERGIC RECEPTOR AGONISTS E.G., NUCLEOTIDES OF ADENOSINE, CYTIDINE AND URIDINE, DINUCLEOTIDES AND ANALOGS; TREATING VAGINAL DRYNESS ASSOCIATED WITH MENOPAUSE, CHEMOTHERAPY, AND DISEASES; VULVAR PAIN | INSPIRE PHARMACEUTICALS, INC. | 2002-10-08 | — | — | US | claimed |
| US-20020013289-A1 | METHOD OF PROMOTING CERVICAL AND VAGINAL SECRETIONS | MERCK SHARP & DOHME CORP. | 2002-01-31 | — | — | US | claimed |
| EP-1140967-A1 | TARGETED GENE TRANSFER USING G PROTEIN COUPLED RECEPTORS | UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2001-10-10 | — | — | EP | claimed |
| WO-2000039145-A1 | TARGETED GENE TRANSFER USING G PROTEIN COUPLED RECEPTORS | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2000-07-06 | — | — | WO | claimed |
| WO-1998028010-A2 | USE OF MOIETIES FOR BINDING TO HYALURONAN AND ICAM-1 | HYAL PHARMACEUTICAL CORPORATION (CA) | 1998-07-02 | — | — | WO | claimed |
| US-20260076960-A1 | METAP2 INHIBITORS AND METHODS OF TREATING OBESITY | SYNDEVRX INC (US) | 2026-03-19 | — | — | US | disclosed |
| US-12577591-B2 | Microorganisms and methods for increasing co-factors | GENOMATICA, INC. (US) | 2026-03-17 | — | — | US | disclosed |
| US-12577594-B2 | Engineered microorganisms and methods for improved aldehyde dehydrogenase activity | GENOMATICA, INC. (US) | 2026-03-17 | — | — | US | disclosed |
| US-20260028651-A1 | METHOD OF PRODUCING & PROCESSING DIAMINES | AGAIN BIO APS (DK) | 2026-01-29 | — | — | US | disclosed |
| US-12503711-B2 | Method of producing and processing diamines to a diamine free base using a carbonate intermediate and an engineered microorganism | GENOMATICA, INC. (US) | 2025-12-23 | — | — | US | disclosed |
| EP-0192442-A2 | Detergency builder system | THE PROCTER & GAMBLE COMPANY (US) | 1986-08-27 | — | — | EP | disclosed |
| EP-0179408-A2 | Amidoalkyl melamines and aminoalkyl melamines, and process for their preparation | BASF Aktiengesellschaft (DE) | 1986-04-30 | — | — | EP | disclosed |
| EP-0073267-B1 | COPPER PHTHALOCYANINE BLUE REACTIVE DYES, PROCESS FOR THEIR PRODUCTION, AND THEIR USE FOR DYEING CELLULOSIC FIBERS | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1985-03-20 | — | — | EP | disclosed |
| US-4396549-A | Copper phthalocyanine blue reactive dye | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1983-08-02 | — | — | US | disclosed |
| US-4131685-A | ADRENERGIC BLOCKING AGENT, CARDIAC STIMULANT | IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) | 1978-12-26 | — | — | US | disclosed |
| US-4069254-A | INHIBITORS OF BLOOD PLATELET AGGREGATION | BANYU PHARMACEUTICAL CO., LTD. (JA) | 1978-01-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12577594-B2 | Engineered microorganisms and methods for improved aldehyde dehydrogenase activity | ACADM, ALDH7A1, ADSL | PAOX 471/4885HIF1A 1689/4885KDM4E 543/4885 |
| US-20260076960-A1 | METAP2 INHIBITORS AND METHODS OF TREATING OBESITY | METAP2, METAP1, LNPEP | PAOX 1744/4885HIF1A 3764/4885KDM4E 2804/4885 |
| US-20260028651-A1 | METHOD OF PRODUCING & PROCESSING DIAMINES | DDC, DAO, ODC1 | PAOX 1178/4885HIF1A 923/4885KDM4E 1463/4885 |
| US-12577591-B2 | Microorganisms and methods for increasing co-factors | ABAT, HADHB, MMAB | PAOX 306/4885HIF1A 2523/4885KDM4E 2135/4885 |
| US-20020013289-A1 | METHOD OF PROMOTING CERVICAL AND VAGINAL SECRETIONS | P2RY4, P2RY2, P2RY1 | PAOX 1741/4885HIF1A 3377/4885KDM4E 4701/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.